The results of GRADEPro GDT were utilized to evaluate all outcomes, and the results indicated that the total effective rate and Lund–Mackay score were moderate-quality evidence, the Lund–Kennedy score was low-quality evidence, and the rest of the SNOT-20 score, nasal congestion VAS score, runny nose VAS score, headache VAS score, olfactory impairment VAS score, TCM syndrome total score, TNF-α, IL-6, and the incidence of adverse reactions were very low-quality evidence, see Figure 19A–G. This evidence concerns the gene IL6 and Headache.